Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hiv infections
Phenotype C0007222|cardiovascular disease
Sentences 18
PubMedID- 25609975 In this review, we describe the epidemiology and pathogenesis of cardiovascular disease in patients with hiv infection and summarize the latest knowledge on the relationship between traditional and novel inflammatory, immune activation, and endothelial dysfunction biomarkers on the cardiovascular risk associated with hiv infection.
PubMedID- 26215596 This finding emphasizes the need to screen for cardiovascular disease among persons with hiv infection in resource-limited settings.
PubMedID- 22952600 hiv infection has been associated with increased cardiovascular disease risk [1] but the mediators of the increased risk have not been specifically identified.
PubMedID- 25226210 Background: microbial translocation has been suggested as a driver of cardiovascular disease in hiv infection.
PubMedID- 23130129 Carotid artery imaging: insights into inflammation and cardiovascular disease risk in patients with hiv infection.
PubMedID- 24297718 cardiovascular diseases associated with hiv infection and their management.
PubMedID- 23109004 In particular, cardiovascular diseases are associated with both hiv infection and antiretroviral treatment, and represent major clinical complications in hiv-positive patients.
PubMedID- 22001083 Primary, secondary, and tertiary prevention of cardiovascular disease in patients with hiv disease: a guide for nurse practitioners.
PubMedID- 21245517 The primary risk factors for cardiovascular disease (cvd) in patients with hiv infection are the same as those for the general population.
PubMedID- 21881685 The aetiology and pathogenesis of cardiovascular disease in hiv infection is still the subject of intense speculation, and is likely multi-factorial.
PubMedID- 25362192 Monocyte activation may increase the risk for cardiovascular disease in individuals with hiv infection.
PubMedID- 25435195 Crp has no predictive value for atherosclerosis, and further research is required to improve early prediction of cardiovascular disease in hiv infection.
PubMedID- 24798779 cardiovascular disease in patients with chronic human immunodeficiency virus infection.
PubMedID- 25081934 Cmv has been extensively linked with cardiovascular disease in patients without hiv infection [13, 14], in both nontransplantion and posttransplantion populations, and the ability of cmv to alter the size and shape of the immune system may be relevant in the context of chronic activation of the vascular endothelium and the inflammatory response.
PubMedID- 21546831 cardiovascular disease in hiv infection.
PubMedID- 22846182 The cardiovascular disease risk associated with hiv infection appears to be partially attenuated by antiretroviral treatment, since treatment interruption increases short-term risk of cardiovascular disease events [11].
PubMedID- 23778059 Through shared pathogenic mechanisms, tobacco use magnifies the independent association of hiv infection with cardiovascular disease, ischemic stroke, peripheral vascular disease, cancer, osteoporosis, and increased mortality.
PubMedID- 22726233 We enrolled 9 hiv infected adults with cardiovascular disease (cvd) risk factors and documented (ultrasound) carotid intima media thickening or non-obstructive plaque, and 5 hiv seronegative adults with no cvd risk factors (table 1).

Page: 1